Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

102
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

89
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

100
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
100
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

120
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
120

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seeing Makes the Difference: Augmented Reality in the OR.

IEEE pulse·2022
Same author

A Life Well Lived: In Memory of Máximo E. Valentinuzzi.

IEEE pulse·2022
Same author

Working Toward Diversity and Inclusion in Neural Engineering.

IEEE pulse·2021
Same author

Harnessing Another Tool for Treating Brain Cancer.

IEEE pulse·2021
Same author

The RADx<sup>SM</sup> Tech Process: Accelerating Innovation for COVID-19 Testing.

IEEE pulse·2021
Same author

Testing PPE: Are DIY Masks a Viable Alternative to Address Shortages?

IEEE pulse·2020
Same journal

The Heart of the Metaverse: How Immersive Technologies Are Revolutionizing Cardiac Care.

IEEE pulse·2026
Same journal

Benefits for Early Diagnosis, Treatment, and Research.

IEEE pulse·2026
Same journal

At the Crossroads of Innovation.

IEEE pulse·2026
Same journal

Robotics in the Cath Lab: Precision, Safety, and the Rise of Remote Cardiac Interventions.

IEEE pulse·2026
Same journal

Industry Corner Live With BioBeat CEO Arik Ben Ishay.

IEEE pulse·2026
Same journal

Engineering the Next Generation of Artificial Hearts.

IEEE pulse·2026
See all related articles

Related Experiment Video

Updated: Nov 16, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.1K

Solving Unmet Needs With Innovative Pediatric Medical Devices.

Cynthia Weber

    IEEE Pulse
    |February 19, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Few life-saving medical devices are approved for pediatric patients, especially infants and neonates. Adult devices are often modified, but these solutions may not meet children

    More Related Videos

    A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation
    04:46

    A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation

    Published on: January 17, 2011

    21.8K
    Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
    09:15

    Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

    Published on: February 10, 2022

    3.9K

    Related Experiment Videos

    Last Updated: Nov 16, 2025

    Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
    09:57

    Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

    Published on: September 20, 2024

    3.1K
    A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation
    04:46

    A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation

    Published on: January 17, 2011

    21.8K
    Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
    09:15

    Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

    Published on: February 10, 2022

    3.9K

    Area of Science:

    • Biomedical Engineering
    • Pediatric Medicine
    • Regulatory Science

    Background:

    • Class III life-saving devices approved by the U.S. Food and Drug Administration (FDA) are rarely designated for pediatric use, with only 24% approved in the last decade.
    • The majority of approved pediatric devices are for older children (over 12 years), with less than 4% specifically labeled for infants and toddlers (0-2 years).
    • Neonatal patients face an even greater scarcity of approved medical devices.

    Purpose of the Study:

    • To highlight the critical gap in life-saving medical device availability for pediatric and neonatal populations.
    • To underscore the challenges and limitations of using repurposed adult devices for young patients.
    • To advocate for the development of novel medical devices tailored to the unique physiological needs of children.

    Main Methods:

    • Analysis of FDA approval data for Class III life-saving medical devices over the past decade.
    • Categorization of approved devices based on patient age group (pediatric vs. adult, and sub-categories within pediatrics).
    • Review of current clinical practices involving the adaptation of adult devices for pediatric use.

    Main Results:

    • A significant underrepresentation of pediatric-use medical devices among FDA-approved Class III devices.
    • A pronounced lack of devices specifically designed and approved for the youngest pediatric age groups (0-2 years) and neonates.
    • Prevalence of the use of modified adult medical devices as a workaround for pediatric and neonatal care.

    Conclusions:

    • There is an urgent unmet need for FDA-approved, life-saving medical devices specifically designed for pediatric and neonatal patients.
    • Repurposing adult devices presents significant limitations and potential risks due to differences in anatomy, physiology, and growth patterns.
    • Further research and development are crucial to create innovative medical technologies that address the unique requirements of young patients.